Globus Medical, Inc. Class A (GMED) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Globus Medical, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.916 Welcome to Globus Medical's first quarter 2026 earnings call. 00:00:04.916 -- 00:00:10.160 At this time, all lines will be on mute, and a Q&A session will be held after the prepared 00:00:10.160 -- 00:00:14.945 remarks. Please be advised that today's conference is being recorded. 00:00:14.945 -- 00:00:20.090 I will now turn the call over to Brian Kearns, Senior Vice President of Business Development 00:00:20.090 -- 00:00:23.173 and Investor Relations. Mr. Kearns, please go ahead. 00:00:23.173 -- 00:00:25.173 Thank 00:00:25.435 -- 00:00:29.427 you, Kathy, and thank you, everyone, for being with us today. 00:00:29.427 -- 00:00:34.596 Joining today's call from Globus Medical will be Keith Feil, President and CEO, 00:00:34.596 -- 00:00:37.901 and Kyle Klein, Chief Financial Officer. 00:00:37.901 -- 00:00:42.869 This review is being made available via webcast accessible through the investor relations 00:00:42.869 -- 00:00:47.814 section of the Globus Medical website at www.globusmedical.com. 00:00:49.320 -- 00:00:53.845 Before we begin, let me remind you that some of the statements made during this review 00:00:53.845 -- 00:00:56.930 are or may be considered forward-looking statements. 00:00:56.930 -- 00:01:02.059 Our Form 10-K for the 2025 fiscal year and our subsequent filings with 00:01:02.059 -- 00:01:06.386 the Securities and Exchange Commission identify certain factors that could cause our 00:01:06.386 -- 00:01:11.134 actual results to differ materially from those projected in any forward-looking statements 00:01:11.134 -- 00:01:18.102 made today. Our SEC filings, including the 10-K, are available on our website. 00:01:18.415 -- 00:01:23.300 We do not undertake to update any forward-looking statements as a result of new informatio...